
Connecticut Innovations (CI) is Connecticut's strategic venture capital arm and the leading source of financing and ongoing support for innovative, growing companies. Founded in 1989, CI invests across sectors including bioscience, climate tech, AI/quantum, and deep tech, primarily at the seed and early stages.
Deal activity increased 500% year-over-year (6 deals in the last 12 months). Average disclosed round size is $18.0M (across 82 rounds with reported amounts).
Portfolio
75
Fund Size
—
Top Stage
Unknown
Last 12 Mo
6
Team
Alison Malloy
Managing Director, Venture Future Fund
Bo Bradstreet
Managing Director, Talent Acquisition
Konstantine Drakonakis
Managing Director, Venture ClimateTech Fund
Brian Dowd
Director, Venture Bioscience
Kimberly Wolfe
Director, Information Technology
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| QQueen One | Unknown | $25M | Aug 2026 |
| Seed | $5M | Jul 2026 | |
| PP2 Science Inc. | Unknown | $23M | May 2026 |
| Series B | $70M | Mar 2026 | |
| Unknown | $12M | Jan 2026 | |
| Unknown | $5M | Jan 2026 | |
| NNeurosoft Bioelectronics | Seed | $7.5M | Jan 2026 |
| Unknown | $25M | Jan 2026 | |
| Series A | $23M | Oct 2025 | |
| Unknown | $3M | Sep 2025 | |
| Seed | $5.3M | Oct 2024 | |
| Series B | $126M | Aug 2024 | |
| Unknown | $17M | May 2024 | |
| Unknown | $6M | Jan 2024 | |
| HHalda Therapeutics | Series B | $126M | Jan 2024 |
| Seed | — | Dec 2023 | |
| PP2 Science Inc. | Series A | $23M | Feb 2023 |
| Unknown | $6M | Jan 2023 | |
| Unknown | $13M | Nov 2022 | |
| TTorigen | Unknown | $13M | Nov 2022 |
| Seed | $3M | Oct 2022 | |
| Series B | $15M | Apr 2022 | |
| Seed | $6M | Feb 2022 | |
| Series B | $27M | Jan 2022 | |
| Series A | $6M | Jan 2022 |
Top Co-Investors
Last updated: 7 October 2026